Cellectis S.A. Number Of Other Equity Instruments Exercisable In Share-based Payment Arrangement
Cellectis S.A. (CLLS) had Number Of Other Equity Instruments Exercisable In Share-based Payment Arrangement of 7.64 million shares as of 2025-12-31, per its 20-F filed 2026-03-20.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement · last filed 2026-03-20
- 2018-12-31: Number Of Other Equity Instruments Exercisable In Share-based Payment Arrangement 633129600.00%.
- 2017-12-31: Number Of Other Equity Instruments Exercisable In Share-based Payment Arrangement 429220800.00%.
pure
| Period end | Number Of Other Equity Instruments Exercisable In Share-based Payment Arrangement |
|---|---|
| 2018-12-31 | 633129600.00% 20-F · filed 2019-03-12 |
| 2017-12-31 | 429220800.00% 20-F · filed 2018-03-13 |
shares
| Period end | Number Of Other Equity Instruments Exercisable In Share-based Payment Arrangement |
|---|---|
| 2025-12-31 | 7.64M shares 20-F · filed 2026-03-20 |
| 2024-12-31 | 8.89M shares 20-F · filed 2025-03-14 |
| 2023-12-31 | 8.25M shares 20-F · filed 2024-04-29 |
| 2022-12-31 | 8.30M shares 20-F · filed 2023-03-14 |
| 2021-12-31 | 8.46M shares 20-F · filed 2022-03-03 |
| 2020-12-31 | 8.90M shares 20-F · filed 2021-03-04 |
| 2019-12-31 | 7.77M shares 20-F · filed 2020-03-05 |